SCHEMBL4932680

SCHEMBL4932680

O=C(O)CNC(=O)c1cc(Cl)c(OCc2cccc(NC3CCC3)c2)c(Cl)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 4/20 0.42
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
PTPN1 P18031 3/20 0.40
PLAU P00749 1/20 0.40
TAOK1 Q7L7X3 1/20 0.40
TAOK3 Q9H2K8 1/20 0.40
SENP5 Q96HI0 1/20 0.39
SENP2 Q9HC62 1/20 0.39
SENP1 Q9P0U3 1/20 0.39
PDE5A O76074 1/20 0.39
TOP2A P11388 1/20 0.38
ALDH1A1 P00352 1/20 0.38
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5717926 0.95 PTPN1 (0.39) MRGPRX4NPC1RAB9AMEN1KMT2A
SCHEMBL4351071 0.90 THRA (0.46) MEN1KMT2ASMN1; SMN2HPGDPTPN1
SCHEMBL4926882 0.88 PDE4A (0.36) MRGPRX4PLAUTAOK1TAOK3ALDH1A1
SCHEMBL5717931 0.87 MRGPRX4 (0.40) MRGPRX4NPC1RAB9AMEN1KMT2A
SCHEMBL4931806 0.86 F2 (0.39) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL4931877 0.86 PDE4A (0.35) MRGPRX4KMT2AMAPTNPSR1PLAU
SCHEMBL4934563 0.85 PTPN1 (0.43) MRGPRX4MEN1KMT2APTPN1PDE5A
SCHEMBL5718186 0.84 PTGDR (0.34) MEN1KMT2APLAUTAOK1TAOK3
SCHEMBL4929677 0.84 MRGPRX4 (0.38) MRGPRX4PLAUTAOK1TAOK3
SCHEMBL4933162 0.84 MRGPRX4 (0.42) MRGPRX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA MRGPRX4 119/4885NPC1 2087/4885RAB9A 986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.